Targeting BCL-2 as a Therapeutic Strategy for Primary P210BCR-Abl1-Positive B-All Cells

In Vivo- Greece

doi 10.21873/invivo.11802

Full Text

Abstract

Available in

Date

Authors

Publisher

Anticancer Research USA Inc.

Related search

Targeting Midbodies in Ovarian Cancer Stem Cells as a Therapeutic Strategy

2014English

Targeting the Metabolism of Leukemia Stem Cells as a Novel Therapeutic Strategy

Drugs in Context
Molecular MedicinePharmacology
2013English

Magnetic Targeting as a Strategy to Enhance Therapeutic Effects of Mesenchymal Stromal Cells

Stem Cell Research and Therapy
GeneticsCell BiologyMolecular BiologyBiochemistryMedicineMolecular Medicine
2017English

BCL-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia

Cancer Research
Cancer ResearchOncology
2019English

Targeting Tankyrase 1 as a Therapeutic Strategy for BRCA-associated Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Utilizing TH9 Cells as a Novel Therapeutic Strategy for Malignancies

OncoImmunology
OncologyAllergyImmunology
2013English

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Targeting the BCL-2 Family for Cancer Therapy

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2012English

Targeting TCTP as a New Therapeutic Strategy in Castration-Resistant Prostate Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy